Merck forecasts slightly higher 2007 profit
Merck & Co.  on Wednesday stood by its forecast of flat earnings for 2006 and projected slightly higher 2007 results, in line with Wall Street expectations, as the drugmaker grapples with generic competition for a number of its medicines.
FRIDAY, Dec. 17 (HealthDayNews) -- Pfizer Inc. said Friday that a study of its popular pain drug Celebrex in cancer patients had found an apparent increased risk of heart attack and other cardiovascular problems.